ESC Premium Access

Ten-year outcomes of first-generation drug-eluting stents results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary revascularization (SIRTAX) VERY LATE Trial

Topic: PCI / stents: devices and technique

Congress Presentation

About the speaker

Professor Lorenz Raber

Swiss Cardiovascular Center, Bern (Switzerland)
13 presentations
3 followers

5 more presentations in this session

Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy (DAPT) Study

Speaker: Doctor C. Resor (Boston, US)

Thumbnail

Prevention of First Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54

Speaker: Doctor M. Bonaca (Aurora, US)

Thumbnail

The Italic/Italic Plus Trial

Speaker: Professor M. Gilard (Brest, FR)

Thumbnail

PCI for Elderly patients at High Bleeding Risk. A substudy of the LEADERS FREE trial

Speaker: Doctor M. Morice (Massy, FR)

Thumbnail

Ad-hoc versus non-ad-hoc percutaneous coronary intervention strategies in patients with stable coronary artery disease.

Speaker: Doctor T. Toyota (Kobe, JP)

Thumbnail

Access the full session

Clinical Trial Update Platelet therapy

Speakers: Professor L. Raber, Doctor C. Resor, Doctor M. Bonaca, Professor M. Gilard, Doctor M. Morice...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb